Latest Headlines

  1. Cambridge Medical Robotics Unveils Its Next-Gen Robotic Surgery System

    Cambridge Medical Robotics Ltd, the private company developing a next-generation robotic system for universal minimal access surgery, today reveals its Versius system as it provides an update on ongoing cadaveric studies.

  2. FDA Officials Discuss Merits And Dangers Of Real-World Evidence

    Fifteen officials from the U.S. Food and Drug Administration (FDA), through an article in the New England Journal of Medicine (NEJM), acknowledge the positive impact of real-world evidence on patient care, safety surveillance, and regulatory practice, but also warn of the pitfalls such evidence could entail if not vetted according to existing evidentiary standards.

  3. Medtronic, Fitbit To Build An App That Tracks Both Activity And Glucose

    Fitbit has pushed further into medtech by inking a partnership with Medtronic. The companies plan to leverage Fitbit’s activity tracking expertise with Medtronic’s continuous glucose monitoring (CGM) systems to develop a an app that will help both patients with type 2 diabetes and their doctors understand the connection between physical activity and glucose levels.

  4. “Neural Tourniquet” Uses Electrical Signals To Staunch Bleeding

    A recent advance in bioelectronic medicine may be able to stop internal or external bleeding by stimulating certain nerves in the brain using a “neural tourniquet.” Researchers from the Feinstein Institute for Medical Research (FIMR) believe the treatment could be used in battlefield medicine, emergency care, surgery, or post-partum treatments to treat or prevent hemorrhaging.

  5. Buyer's Remorse: Abbott Files Suit To Nix Proposed Alere Merger

    Abbott says it has filed a complaint with the Delaware Court of Chancery to end its proposed deal to buy point-of-care (POC) diagnostics company Alere, which Abbott believes has lost "significant value due to numerous damaging business developments" since their $5.8 billion merger agreement was announced in late January.

  6. St. Jude’s Spinal Cord Stimulation System Deemed Full-Body MRI-Safe In EU

    St. Jude Medical, Inc., a global medical device company, recently announced CE mark approval for full-body magnetic resonance (MR) conditional labeling of the Proclaim Elite Spinal Cord Stimulation (SCS) System.

  7. Exact Imaging’s Micro-Ultrasound System Gains FDA Clearance

    Exact Imaging (, the world's leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance of the prostate, announced it has received FDA 510(k) Clearance for its ExactVu™ micro-ultrasound system.

  8. Senate Ends Debate Over “Cures;” Bill Expected To Pass This Week

    A cloture vote by the U.S. Senate on Tuesday has ended debate in the Senate over the 21st Century Cures Act and paved the way for a vote on passage of the bill, which could happen as soon as today. Under cloture, a procedure intended to break filibusters, the Senate may limit consideration of a pending matter to 30 additional hours of debate.

  9. J&J, S&N Lead $7 Million Financing Into OrthoSpace

    Johnson & Johnson (J&J) and Smith & Nephew (S&N) led investors pouring $7 million in equity funding into OrthoSpace, which intends to use the money to support its ongoing U.S. Investigational Device Exemption (IDE) trial and commercialization activities.

  10. Series 9.5 ADPs With Enhanced NIR Sensitivity Up To 950 nm

    The new Series 9.5 avalanche photodiodes from First Sensor feature an increased sensitivity in the near infrared (NIR) wavelength range up to 950 nm. Due to its fast rise time and very low dark current the photodiodes are ideal for applications with low light intensities and high modulation frequencies such as laser rangefinding and laser scanning.